$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Splenic artery aneurysms (SAA) are recognized as the most common type of visceral artery aneurysms (VAAs), comprising approximately 60% of such cases1. These aneurysms can carry a significant risk of rupture when meeting size criteria (more than 3 cm) or in pregnancy with an increased plasma volume and cardiac output, leading to potentially life-threatening hemorrhage2. Historically, the management of SAA has included open surgical repair and conservative management (non-operative management for patients not meeting size criteria, pseudoaneurysm morphology, or not young fertile women)3,4. Over the past decade, endovascular (EV) approaches have been increasingly utilized due to their less invasive nature and favorable short-term outcomes compared to open repair5.
Recent studies comparing endovascular and open-surgical approaches for SAA management have shown promising results for endovascular techniques. Endovascular repair is associated with lower complication rates, shorter hospital stays, and reduced resource utilization compared to open surgery5,6. A meta-analysis found significantly lower overall mortality rates with endovascular repair7. However, randomized trials showed similar splenectomy rates and technical options for both approaches, with laparoscopy offering shorter procedures and lower morbidity8. While endovascular repair demonstrates advantages in perioperative outcomes9, the need for reintervention after endovascular repair remains a concern, with freedom from reintervention at 3 years postoperatively reported as 82.4%, mostly due to sac reperfusion6. These findings suggest that endovascular repair may be a preferred initial strategy for SAA management, but further comparative studies are needed.
Robotic-assisted and laparoscopic surgery have emerged as viable minimally invasive options for treating SAA. These approaches demonstrate comparable operative times, low open conversion rates, and reduced morbidity compared to open surgery2. Robotic-assisted laparoscopic surgery allows for complex procedures, including aneurysm excision with arterial reconstruction, and shows promising mid-term results4,9. A randomized study comparing open and laparoscopic SAA management found that laparoscopy permitted multiple technical options without increasing splenectomy rates while reducing postoperative complications and hospital stay8. However, laparoscopic arterial anastomoses showed poor long-term results. Complex vascular reconstructions have now been demonstrated in the transplant literature and by international vascular surgeons on the DaVinci Xi platform, emphasizing the increased dexterity and wristed instrument of the robotic platform, a prior limitation of laparoscopic surgery10. Both robotic and laparoscopic approaches result in shorter hospital stays and lower overall morbidity rates compared to open surgery2,8. These minimally invasive techniques represent important advancements in SAA treatment, offering tailored options for patients, particularly those at high surgical risk.
Despite these advancements, the rarity of SAA has precluded the conduct of large randomized controlled trials, resulting in a reliance on case reports and series to inform clinical practice4. Existing literature indicates that while endovascular approaches may offer superior short-term results, they also require more reinterventions compared to open surgery, which is associated with fewer late complications5. Moreover, splenic infarction and pancreatitis are noted as common complications in minimally invasive approaches11.
By examining this case, we aim to provide further insights into the technical details of robotic-assisted laparoscopic surgery for SAA by providing a comprehensive protocol. This paper and accompanying video will serve as a template to instruct robotic instrument selection, port placement and DaVinci Xi robot docking, gastropexy for visualization, exposure of a distal splenic artery aneurysm, vascular control of feeding and draining arteries, and ligation of a splenic artery aneurysm.
CASE PRESENTATION:
A 38-year-old Caucasian female presented to the vascular surgery clinic for evaluation after an incidental finding of a distal splenic artery aneurysm found on an MRI performed for evaluation of adrenal glands. She had a surgical history of prior C-sections and no other significant medical history. Her home medications included Aspirin 81 mg daily, folic acid, fish oil, and prenatal vitamins. She was undergoing fertility treatments with plans for in vitro fertilization this year. She drank alcohol socially and denied tobacco and drug use. In regard to the SAA, she was asymptomatic, and on review of her imaging, there were no other visceral aneurysms identified. The physical exam was unremarkable other than a well-healed Pfannenstiel incision.
Diagnosis, assessment, and plan
The decision was made to obtain new contrasted CT imaging to investigate the anatomy of the splenic artery aneurysm and allow for surgical planning. CTA Abdomen/pelvis showed a 2.2 cm x 1.9 cm distal 1/3 splenic artery aneurysm with two draining branches and one feeding artery. All arteries showed high levels of tortuosity (Figure 1A-B). The patient was counseled about the recommendation for repair, given her plan for the upcoming pregnancy, which would place her at increased risk for an aneurysm rupture. She agreed to surgical repair but requested to avoid the endovascular approach as she did not want to have increased exposure to radiation in her operation and follow-up course, given her fertility treatments and plans for upcoming assisted pregnancy. The options of open surgery through midline laparotomy with a plan for splenic artery aneurysm repair versus robotic-assisted laparoscopic splenic artery aneurysm resection and possible repair were described to her. She opted for the minimally invasive robotic-assisted approach. Risks and consequences, including but not limited to perioperative bleeding, perioperative pancreatitis, splenic artery occlusion and infarct of the spleen, secondary infections, the need for blood transfusions, splenectomy, and the need for post-splenectomy vaccines, were discussed with the patient in detail. All questions were answered, and she wished to proceed.